Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis
Neurol 98:e2368-e2376, Molimard, A.,et al, 2022
See this aricle in Pubmed

Article Abstract
The use of rituximab has increased in France over the last 10 years as a first-line immunosuppressant. This study suggests good tolerability and efficacy of rituximab in juvenile myasthenia gravis. Early use appears to improve outcomes and facilitate cortisone sparing in antibody-positive generalized juvenile myasthenia.
 
Related Tags
(click to filter results - removes previous filter)

children
immunosuppressive agents
myasthenia gravis
myasthenia gravis,infantile and juvenile
myasthenia gravis,treatment of
prognosis
rituximab
treatment of neurologic disorder

Click Here to return To Results